Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research entities : Gilead sciences, inc. save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Gilead to Present Late-Breaking Data and Real-World Evidence Highlighting Innovative Antiviral Portfolio and Research Pipeline at CROI 2024
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.07%
H: 0.53%
C: -0.75%
antiviral pipeline research
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.01%
H: 1.59%
C: 0.63%
antibody collaboration agreement
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published: 2023-11-29 (Crawled : 15:30) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -0.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.35%
H: 1.23%
C: 0.38%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.46%
H: 0.8%
C: 0.51%
research hypertension market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.69%
H: 0.06%
C: -0.68%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.82%
C: 0.75%
reach research hiv market
Kite’s Car T-cell Therapy Yescarta® Demonstrates High Response Rate and Durable Remission in ALYCANTE Study as Initial Treatment for Transplant Ineligible Patients With Relapsed/Refractory Large B-cell Lymphoma
Published: 2023-09-18 (Crawled : 09:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.25%
H: 0.38%
C: -0.32%
yescarta t-cell treatment response therapy study
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: 3.09%
H: 3.59%
C: 1.4%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.39%
H: 0.06%
C: -2.33%
research program milestone
Gilead Announces Partial Clinical Hold for Magrolimab Studies in AML
Published: 2023-08-21 (Crawled : 13:20) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.28%
H: 0.78%
C: 0.36%
aml
Anti-Ageing Drugs Market to Amass Notable Gains by 2029 Says Brandessence Market Research
Published: 2023-06-15 (Crawled : 14:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.38%
H: 0.07%
C: -0.63%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.95%
H: 1.62%
C: 1.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.42%
H: 0.93%
C: 0.92%
research market
Gilead to Present Latest Liver Disease Research at the European Association for the Study of the Liver (EASL) Congress 2023
Published: 2023-06-14 (Crawled : 09:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.52%
H: 0.46%
C: -0.12%
liver disease association research study
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published: 2023-06-08 (Crawled : 22:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.41%
H: 0.68%
C: 0.64%
PGEN | $1.33 0.76% 0.75% 1M
|
Health Technology
|
| O: 0.0%
H: 0.76%
C: -4.55%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.63%
H: 1.87%
C: -1.25%
ITOS | $10.58 2.42% 2.36% 940K
|
Health Technology
|
| O: -0.52%
H: 3.23%
C: -2.2%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.42%
H: 3.56%
C: 3.48%
cancer
Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research
Published: 2023-05-15 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.78%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.22%
H: 0.14%
C: -0.2%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.35%
H: 0.83%
C: -0.73%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.17%
H: 1.07%
C: 0.19%
QCOM | $157.65 -2.35% -2.4% 10M
|
Electronic Technology
|
| O: 0.14%
H: 2.54%
C: 2.43%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.13%
H: 0.42%
C: 0.4%
health research global home market
Size of Microalgae Market to Grow at 4.5% CAGR and Reach $4996.8 Million by 2027: Brandessence Market Research
Published: 2023-05-15 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.78%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.22%
H: 0.14%
C: -0.2%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.35%
H: 0.83%
C: -0.73%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.17%
H: 1.07%
C: 0.19%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.13%
H: 0.42%
C: 0.4%
CYAN | $0.33 -0.03% 38K
|
Health Technology
|
| O: -4.76%
H: 3.0%
C: 0.0%
reach research market
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: 1.79%
H: 0.18%
C: -0.06%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.61%
H: 0.3%
C: 0.24%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 0.14%
C: -0.78%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.22%
H: 0.14%
C: -0.2%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.35%
H: 0.83%
C: -0.73%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.17%
H: 1.07%
C: 0.19%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.13%
H: 0.42%
C: 0.4%
research global growth market
CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.2%
H: 0.09%
C: -1.37%
hepcludex hepatitis chmp authorization positive treatment virus
Gilead Sciences: 4 Questions: Global Experts Convene To Identify Key Measures to Long-Term Success in HIV
Published: 2023-04-12 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.52%
H: 0.33%
C: -0.98%
success global hiv
HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-26 (Crawled : 13:20) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
SYNH | $42.98 0.0% 7.4M
|
Health Services
| Email alert
Add to watchlist
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
covid-19 trials research global report hiv impact study market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-03 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.02%
H: 2.67%
C: 0.18%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.83%
H: 1.33%
C: -0.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.43%
H: 0.41%
C: 0.25%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.4%
H: 2.75%
C: 1.52%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.72%
H: 1.29%
C: 1.04%
covid-19 treatment research global report impact health market
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
Published: 2022-10-18 (Crawled : 13:20) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.24%
H: 0.8%
C: 0.5%
research hiv
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.